Caris Life Sciences, Stock Performance
| CAI Stock | USD 28.24 0.24 0.86% |
The firm shows a Beta (market volatility) of 0.88, which signifies possible diversification benefits within a given portfolio. Caris Life returns are very sensitive to returns on the market. As the market goes up or down, Caris Life is expected to follow. Caris Life Sciences, right now shows a risk of 3.46%. Please confirm Caris Life Sciences, kurtosis, and the relationship between the maximum drawdown and rate of daily change , to decide if Caris Life Sciences, will be following its price patterns.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Caris Life Sciences, has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Caris Life is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders. ...more
Actual Historical Performance (%)
One Day Return 0.86 | Five Day Return 1.36 | Year To Date Return 0.86 | Ten Year Return 0.86 | All Time Return 0.86 |
1 | Caris Life Sciences to Share Six Collaborative Studies at ESMO 2025 | 10/14/2025 |
2 | Caris Life Sciences Revenue Forecast to Rise 21 percent Annually Heading Into Earnings Season | 11/06/2025 |
3 | Acquisition by Spetzler David Baxley of 400 shares of Caris Life at 23.85 subject to Rule 16b-3 | 11/07/2025 |
4 | Top Executive Makes Bold Move with Major Stock Purchase in Caris Life Sciences - TipRanks | 11/10/2025 |
5 | Caris Precision Oncology Alliance Fellows Forum Welcomes 20252026 Class | 11/21/2025 |
6 | CAI Partners with United Way of the Greater Lehigh Valley and The Salvation Army of the Lehigh Valley to Help Families Stay Housed This Holiday Season | 12/03/2025 |
7 | Acquisition by Denton John Russel of 4184 shares of Caris Life at 24.09 subject to Rule 16b-3 | 12/05/2025 |
8 | Can Caris Life Sciences,Inc. Climb 32.81 percent to Reach the Level Wall Street Analysts Expect | 12/08/2025 |
9 | Disposition of 650 shares by Brille Brian J of Caris Life subject to Rule 16b-3 | 12/10/2025 |
10 | Cannaccord Genuity Asserts Hold Stance on Caris Life Sciences, Inc. On Oncology Pipeline Development | 12/11/2025 |
11 | Power Luke Thomas sells Caris Life Sciences stock for 1.65m - Investing.com | 12/12/2025 |
12 | Reassessing Caris Life Sciences Valuation After Recent Share Price Pullback and Short-Term Rebound | 12/16/2025 |
13 | Disposition of 10000 shares by Gary Sawka of Caris Life at 5.6 subject to Rule 16b-3 | 12/19/2025 |
| Begin Period Cash Flow | 60 M | |
| Total Cashflows From Investing Activities | 52.9 M | |
| Free Cash Flow | -253.6 M |
Caris Life Relative Risk vs. Return Landscape
If you would invest 2,919 in Caris Life Sciences, on September 26, 2025 and sell it today you would lose (95.00) from holding Caris Life Sciences, or give up 3.25% of portfolio value over 90 days. Caris Life Sciences, is generating 0.0084% of daily returns assuming volatility of 3.4562% on return distribution over 90 days investment horizon. In other words, 31% of stocks are less volatile than Caris, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Caris Life Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Caris Life's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Caris Life Sciences,, and traders can use it to determine the average amount a Caris Life's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0024
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CAI |
Based on monthly moving average Caris Life is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Caris Life by adding Caris Life to a well-diversified portfolio.
Caris Life Fundamentals Growth
Caris Stock prices reflect investors' perceptions of the future prospects and financial health of Caris Life, and Caris Life fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Caris Stock performance.
| Profit Margin | (0.60) % | ||||
| Operating Margin | (0.48) % | ||||
| Current Valuation | 8.33 B | ||||
| Shares Outstanding | 283.56 M | ||||
| Price To Earning | 17.74 X | ||||
| Price To Sales | 17.55 X | ||||
| Revenue | 412.26 M | ||||
| Gross Profit | 211.38 M | ||||
| EBITDA | (182.95 M) | ||||
| Net Income | (281.89 M) | ||||
| Cash And Equivalents | 38.81 M | ||||
| Cash Per Share | 2.26 X | ||||
| Total Debt | 424.26 M | ||||
| Debt To Equity | 2.41 % | ||||
| Current Ratio | 0.45 X | ||||
| Book Value Per Share | (18.45) X | ||||
| Cash Flow From Operations | (245.2 M) | ||||
| Earnings Per Share | (1.25) X | ||||
| Market Capitalization | 7.94 B | ||||
| Total Asset | 343.73 M | ||||
| Retained Earnings | (2.47 B) | ||||
| Working Capital | 50.31 M | ||||
| Current Asset | 131.15 M | ||||
| Current Liabilities | 215.06 M | ||||
About Caris Life Performance
By evaluating Caris Life's fundamental ratios, stakeholders can gain valuable insights into Caris Life's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Caris Life has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Caris Life has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 61.86 | 88.14 | |
| Return On Tangible Assets | (0.87) | (0.83) | |
| Return On Capital Employed | (1.44) | (1.37) | |
| Return On Assets | (0.82) | (0.78) | |
| Return On Equity | 0.11 | 0.13 |
Things to note about Caris Life Sciences, performance evaluation
Checking the ongoing alerts about Caris Life for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Caris Life Sciences, help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Caris Life Sciences, had very high historical volatility over the last 90 days | |
| Caris Life Sciences, has 424.26 M in debt with debt to equity (D/E) ratio of 2.41, meaning that the company heavily relies on borrowing funds for operations. Caris Life Sciences, has a current ratio of 0.44, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Note however, debt could still be an excellent tool for Caris to invest in growth at high rates of return. | |
| The entity reported the last year's revenue of 412.26 M. Reported Net Loss for the year was (281.89 M) with profit before taxes, overhead, and interest of 211.38 M. | |
| Caris Life Sciences, has about 38.81 M in cash with (245.2 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.26. | |
| Roughly 48.0% of Caris Life shares are held by company insiders | |
| Latest headline from simplywall.st: Reassessing Caris Life Sciences Valuation After Recent Share Price Pullback and Short-Term Rebound |
- Analyzing Caris Life's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Caris Life's stock is overvalued or undervalued compared to its peers.
- Examining Caris Life's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Caris Life's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Caris Life's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Caris Life's stock. These opinions can provide insight into Caris Life's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Caris Stock analysis
When running Caris Life's price analysis, check to measure Caris Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Caris Life is operating at the current time. Most of Caris Life's value examination focuses on studying past and present price action to predict the probability of Caris Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Caris Life's price. Additionally, you may evaluate how the addition of Caris Life to your portfolios can decrease your overall portfolio volatility.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |